France – Produits pharmaceutiques – Fourniture de médicaments du système digestif, cardiologie et métabolisme nécessaires aux Membres du Groupement de Commandes participant à la présente procédure figurant dans les annexes 1A-1B-1C du CCAP. La présente consultation comporte 350 lots. Le descriptif technique et les quantités prévisionnelles sont estimées pour 1 an et sont détaillées dans : - l’annexe : GFC_PHARMA_AO_ME264_CCAP_anne

DeadlineMay 21, 2026 at 11:59 PMCloses tomorrow

AI summary

This tender concerns the supply of pharmaceutical products for digestive system, cardiology, and metabolic disorders needed by members of a purchasing group. The procurement comprises 350 lots with technical specifications and estimated quantities detailed in the tender documents, covering a one-year supply period.

#pharmaceutical supply#digestive medicines#cardiology#metabolic drugs#france#hospital procurement#group purchasing
Fit for

Pharmaceutical wholesalers and distributors licensed to supply medicines in France and approved to serve hospital purchasing groups should bid.

Key requirements

Suppliers must be authorized pharmaceutical distributors capable of supplying the specified medicines across all 350 lots. Compliance with pharmaceutical regulations and ability to meet technical specifications for digestive, cardiology, and metabolic products is required.

Frequently asked questions

  • What is this tender about?

    This tender concerns the supply of pharmaceutical products for digestive system, cardiology, and metabolic disorders needed by members of a purchasing group. The procurement comprises 350 lots with technical specifications and estimated quantities detailed in the tender documents, covering a one-year supply period.

  • What are the requirements for suppliers?

    Suppliers must be authorized pharmaceutical distributors capable of supplying the specified medicines across all 350 lots. Compliance with pharmaceutical regulations and ability to meet technical specifications for digestive, cardiology, and metabolic products is required.

  • What type of company should bid?

    Pharmaceutical wholesalers and distributors licensed to supply medicines in France and approved to serve hospital purchasing groups should bid.

  • Who is the buyer?

    The buyer is CHU BESANCON.

  • When does this tender close?

    Submissions close on May 21, 2026.

  • What is the estimated value?

    The estimated value is 35,800,000 EUR.

Fourniture de médicaments du système digestif, cardiologie et métabolisme nécessaires aux Membres du Groupement de Commandes participant à la présente procédure figurant dans les annexes 1A-1B-1C du CCAP. La présente consultation comporte 350 lots. Le descriptif technique et les quantités prévisionnelles sont estimées pour 1 an et sont détaillées dans : - l’annexe : GFC_PHARMA_AO_ME264_CCAP_anne

Buyer
CHU BESANCON
Buyer ID: 26250176000264·Pharmacie secteur des Médicaments
3 Boulevard A. Fleming, BESANCON Cedex, 25030
Body responsible for review procedures
Tribunal administratif de BESANCON
Buyer ID: 17250005000015
30 rue Charles Nodier, BESANCON Cedex, 25044

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…